Avalyn Pharma, Inc. (AVLN)
26.04
-1.21
(-4.44%)
USD |
NASDAQ |
Oct 23, 16:00
26.04
0.00 (0.00%)
After-Hours: 19:14
Avalyn Pharma Price to Book Value : 2.898 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 3.033 |
| October 21, 2026 | 2.795 |
| October 20, 2026 | 2.741 |
| October 19, 2026 | 2.596 |
| October 16, 2026 | 2.633 |
| October 15, 2026 | 2.742 |
| October 14, 2026 | 2.636 |
| October 13, 2026 | 2.642 |
| October 12, 2026 | 2.760 |
| October 09, 2026 | 2.867 |
| October 08, 2026 | 2.862 |
| October 07, 2026 | 2.841 |
| October 06, 2026 | 2.830 |
| October 05, 2026 | 3.008 |
| October 02, 2026 | 3.131 |
| October 01, 2026 | 3.052 |
| September 30, 2026 | 3.171 |
| September 29, 2026 | 3.016 |
| September 28, 2026 | 3.152 |
| September 25, 2026 | 3.125 |
| September 24, 2026 | 3.177 |
| September 23, 2026 | 3.302 |
| September 22, 2026 | 3.612 |
| September 21, 2026 | 3.519 |
| September 18, 2026 | 3.508 |
| Date | Value |
|---|---|
| September 17, 2026 | 3.720 |
| September 16, 2026 | 3.863 |
| September 15, 2026 | 3.815 |
| September 14, 2026 | 3.893 |
| September 11, 2026 | 3.736 |
| September 10, 2026 | 3.858 |
| September 09, 2026 | 3.993 |
| September 08, 2026 | 4.187 |
| September 04, 2026 | 4.161 |
| September 03, 2026 | 3.944 |
| September 02, 2026 | 3.960 |
| September 01, 2026 | 3.926 |
| August 31, 2026 | 3.865 |
| August 28, 2026 | 3.861 |
| August 27, 2026 | 4.063 |
| August 26, 2026 | 4.122 |
| August 25, 2026 | 4.251 |
| August 24, 2026 | 4.195 |
| August 21, 2026 | 4.270 |
| August 20, 2026 | 4.132 |
| August 19, 2026 | 4.337 |
| August 18, 2026 | 4.325 |
| August 17, 2026 | 4.257 |
| August 14, 2026 | 4.368 |
| August 13, 2026 | 4.071 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.4923 |
| CorMedix, Inc. | 1.325 |
| Eloxx Pharmaceuticals, Inc. | 1.116 |
| Breakthrough Chemistry, Inc. | 2.151 |
| BioStem Technologies, Inc. | 1.020 |
Price to Book Value Related Metrics
| Price | 26.04 |
| Earnings Yield | -8.10% |
| Market Cap | 1.154B |